Baseline characteristics of patients with primary unresectable pancreatic neoplasm
| Patients | 132 |
| Female/male | 75/57 |
| Age, median (IQR) | 74 (64–81) |
| Age ≤65/>65 years (%) | 40/92 (30/70) |
| Tumour diameter ≤4.3 cm (%) | 66 (50) |
| Tumour diameter >4.3 cm (%) | 66 (50) |
| Liver metastases (%) | 60 (45) |
| Performance status, corresponding to Karnofsky index >50% | 57 (43) |
| Chemotherapy started with gemcitabine (%) | 57 (43) |
| Second-line chemotherapy after gemcitabine treatment (%) | 12 (9) |